{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:33:09Z","timestamp":1769149989547,"version":"3.49.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science Foundation for Young Scientists of China","award":["81800325"],"award-info":[{"award-number":["81800325"]}]},{"name":"Science and Technology Planning Project of Guangzhou City","award":["201906010089"],"award-info":[{"award-number":["201906010089"]}]},{"name":"Medical Science and Technology Research Funding of Guangdong","award":["A2017347"],"award-info":[{"award-number":["A2017347"]}]},{"name":"China Youth Research Funding","award":["2017-CCA-VG-018"],"award-info":[{"award-number":["2017-CCA-VG-018"]}]},{"name":"Medjaden Academy & Research Foundation for Young Scientists","award":["MJR20160025"],"award-info":[{"award-number":["MJR20160025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11255-019-02308-w","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T04:49:24Z","timestamp":1571806164000},"page":"2267-2272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The effect of trimetazidine on preventing contrast-induced nephropathy after cardiac catheterization"],"prefix":"10.1007","volume":"51","author":[{"given":"Xingji","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8568-623X","authenticated-orcid":false,"given":"Yuanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"issue":"12","key":"2308_CR1","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","volume":"27","author":"D Fliser","year":"2012","unstructured":"Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W (2012) A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 27(12):4263\u20134272","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2308_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jcin.2011.08.017","volume":"5","author":"G Marenzi","year":"2012","unstructured":"Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL (2012) Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trial. JACC Cardiovasc Interv 5(1):90\u201397","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2308_CR3","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1681\/ASN.2016010021","volume":"28","author":"E Wilhelm-Leen","year":"2017","unstructured":"Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28(2):653\u2013659","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2308_CR4","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.amjcard.2014.05.009","volume":"114","author":"M Abe","year":"2014","unstructured":"Abe M, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Toma M, Tamura T, Haruna Y, Kita T, Kimura T (2014) Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. Am J Cardiol 114(3):362\u2013368","journal-title":"Am J Cardiol"},{"issue":"6","key":"2308_CR5","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.cjca.2017.03.008","volume":"33","author":"L Azzalini","year":"2017","unstructured":"Azzalini L, Garciamoll X (2017) On contrast-induced acute kidney injury, risk prediction, and the future of predictive model development. Can J Cardiol 33(6):711\u2013713","journal-title":"Can J Cardiol"},{"issue":"4","key":"2308_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11936-018-0621-3","volume":"20","author":"AE Afshar","year":"2018","unstructured":"Afshar AE, Parikh PB (2018) Prevention of contrast and radiation injury during coronary angiography and percutaneous coronary intervention. Curr Treat Options Cardiovasc Med 20(4):32","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2308_CR7","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1155\/2018\/5727309.eCollection","volume":"5727309","author":"D Patschan","year":"2018","unstructured":"Patschan D, Buschmann I, Ritter O (2018) Contrast-induced nephropathy: update on the use of crystalloids and pharmacological measures. Int J Nephrol 5727309:2018. \nhttps:\/\/doi.org\/10.1155\/2018\/5727309.eCollection","journal-title":"Int J Nephrol"},{"issue":"4","key":"2308_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/0003319718780551","volume":"70","author":"MS Kallistratos","year":"2019","unstructured":"Kallistratos MS, Poulimenos LE, Giannitsi S (2019) Trimetazidine in the prevention of tissue ischemic conditions. Angiology 70(4):291\u2013298","journal-title":"Angiology"},{"issue":"10","key":"2308_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1358\/mf.2008.30.10.1316831","volume":"30","author":"B Aygen","year":"2008","unstructured":"Aygen B, Celiker H, Dogukan A, Ilhan N (2008) The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease. Methods Find Exp Clin Pharmacol 30(10):757\u2013760","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"9","key":"2308_CR10","doi-asserted-by":"publisher","first-page":"e6059","DOI":"10.1097\/MD.0000000000006059","volume":"96","author":"Z Ye","year":"2017","unstructured":"Ye Z, Lu H, Su Q, Guo W, Dai W, Li HQ, Hf Yang, Li L (2017) Clinical effect of trimetazidine on prevention of contrast-induced nephropathy in patients with renal insufficiency: an updated systematic review and meta-analysis. Medicine 96(9):e6059","journal-title":"Medicine"},{"issue":"5","key":"2308_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.carrev.2017.02.006","volume":"18","author":"TA Ibrahim","year":"2017","unstructured":"Ibrahim TA, El-Mawardy RH, El-Serafy AS, El-Fekky EM (2017) Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease. Cardiovasc Revasc Med 18(5):315\u2013319","journal-title":"Cardiovasc Revasc Med"},{"issue":"2","key":"2308_CR12","first-page":"292","volume":"21","author":"MM Rahman","year":"2012","unstructured":"Rahman MM, Haque SS, Rokeya B, Siddique MA, Banerjee SK, Ahsan SA, Rahman F, Mahmood M, Ahmed K, Bhuiyan MM (2012) Trimetazidine in the prevention of contrast induced nephropathy after coronary angiogram. Mymensingh Med J 21(2):292\u2013299","journal-title":"Mymensingh Med J"},{"issue":"5","key":"2308_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/MAJ.0000000000000575","volume":"350","author":"W Liu","year":"2015","unstructured":"Liu W, Ming Q, Shen J, Wei Y, Li W, Chen W, Xu Y (2015) Trimetazidine prevention of contrast-induced nephropathy in coronary angiography. Am J Med Sci 350(5):398\u2013402","journal-title":"Am J Med Sci"},{"issue":"9","key":"2308_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"12","key":"2308_CR15","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul F, Aj VDM, Reimer P, Webb JA, Thomsen HS, Morcos SK, Alm\u00e9n T, Aspelin P, Bellin MF, Clement O (2011) Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol 21(12):2527\u20132541","journal-title":"Eur Radiol"},{"issue":"4","key":"2308_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.mric.2017.06.012","volume":"25","author":"T Scharnweber","year":"2017","unstructured":"Scharnweber T, Alhilali L, Fakhran S (2017) Contrast-induced acute kidney injury: pathophysiology, manifestations, prevention, and management. Magn Reson Imaging Clin N Am 25(4):743\u2013753","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"2308_CR17","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.12659\/MSM.895543","volume":"21","author":"N Wang","year":"2015","unstructured":"Wang N, Wei RB, Li QP, Yang X, Li P, Huang MJ, Wang R, Cai GY, Chen XM (2015) Renal protective effect of probucol in rats with contrast-induced nephropathy and its underlying mechanism. Med Sci Monit 21:2886\u20132892","journal-title":"Med Sci Monit"},{"issue":"2","key":"2308_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0167-5273(00)00443-5","volume":"77","author":"PG Steg","year":"2001","unstructured":"Steg PG, Grollier G, Gallay P, Morice M, Karrillon GJ, Benamer H, Kempf C, Laperche T, Arnaud P, Sellier P (2001) A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction. Int J Cardiol 77(2):263\u2013273","journal-title":"Int J Cardiol"},{"issue":"2","key":"2308_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000375289","volume":"131","author":"N Zhang","year":"2015","unstructured":"Zhang N, Lei J, Liu Q, Huang W, Xiao H, Lei H (2015) The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis. Cardiology 131(2):86\u201396","journal-title":"Cardiology"},{"issue":"6","key":"2308_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/hrt.2006.097477","volume":"93","author":"AO Onbasili","year":"2007","unstructured":"Onbasili AO, Yeniceriglu Y, Agaoglu P, Karul A, Tekten T, Akar H, Discigil Guzel (2007) Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures. Heart 93(6):698\u2013702","journal-title":"Heart"},{"issue":"3","key":"2308_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.amjcard.2014.04.052","volume":"114","author":"M Shehata","year":"2014","unstructured":"Shehata M (2014) Impact of trimetazidine on incidence of myocardial injury and contrast-induced nephropathy in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention. Am J Cardiol 114(3):389\u2013394","journal-title":"Am J Cardiol"},{"issue":"60","key":"2308_CR22","doi-asserted-by":"publisher","first-page":"102521","DOI":"10.18632\/oncotarget.19519","volume":"8","author":"Z Ye","year":"2017","unstructured":"Ye Z, Lu H, Su Q, Xian X, Li L (2017) Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency. Oncotarget 8(60):102521\u2013102530","journal-title":"Oncotarget"},{"issue":"8","key":"2308_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1592\/phco.2005.25.8.1095","volume":"25","author":"SJ Shalansky","year":"2012","unstructured":"Shalansky SJ, Vu T, Pate GE, Levin A, Humphries KH, Webb JG (2012) N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? Pharmacotherapy 25(8):1095\u20131103","journal-title":"Pharmacotherapy"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-019-02308-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02308-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T23:19:34Z","timestamp":1603235974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-019-02308-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2308"],"URL":"https:\/\/doi.org\/10.1007\/s11255-019-02308-w","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"8 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of the present manuscript have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}